Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.315 USD | -0.22% | +0.13% | -0.30% |
15/05 | Compugen Names David Silberman CFO | MT |
09/05 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.30% | 94.26M | |
+69.72% | 62.86B | |
-1.46% | 41.38B | |
+45.26% | 40.38B | |
-8.93% | 27.64B | |
+12.69% | 26.46B | |
-21.90% | 18.9B | |
+4.57% | 12.67B | |
+25.79% | 12.27B | |
+28.73% | 12.07B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Earnings Flash (ORMP) ORAMED PHARMACEUTICALS Reports Q3 Revenue $682,000